Advertisement
International
Subscribe to International
View Sample

FREE Email Newsletter

Shire drug approved by European regulators for Lexington manufacturing

June 24, 2011 11:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Shire plc's new Lexington manufacturing site has won approval from the European Medicines Agency for the purification of the company's Fabry disease treatment Replagal.

Positive Phase 2 data move Curis toward milestone payment

June 20, 2011 10:48 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Curis Inc. of Lexington received positive data from a pivotal Phase 2 trial of its GDC-0449 drug candidate for advanced basal cell carcinoma that will allow its partner Genentech to file for a new drug application in the second half of this year, triggering a milestone payment for Curis.

Ximedica continues growth pattern with new Minn. office

June 7, 2011 10:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Ximedica LLC, a Providence, R.I.-based medical device firm, has followed up expansion plans announced last year with the opening of a new office in Minneapolis, Minn., where the company will focus on its Midwest healthcare clients.

Advertisement

Biogen's Avonex Pen gets European OK

June 7, 2011 10:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

After receiving a positive recommendation in April from a European regulatory panel, Biogen Idec Inc. has won approval from the European Commission for its Avonex Pen to treat patients with relapsing multiple sclerosis.

Parexel to provide clinical services to Pfizer

May 26, 2011 9:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Parexel International Corp., the Waltham-based contract research organization, said it was selected as one of two strategic partners by Pfizer Inc. to provide clinical development services.

AstraZeneca, Biogen look externally for new drug candidates

May 23, 2011 10:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

AstraZeneca Plc and Biogen Idec Inc. have joined the ranks of local large biotech and pharmaceutical companies like Pfizer Inc., which, facing looming patent expirations and unproductive pipelines, are reaching outside their own walls to find new drug candidates.

Biogen MS drug to aid walking nears European approval

May 20, 2011 9:49 am | by Mass High Tech: The Journal of New England Technology | News | Comments

An oral drug candidate developed by Biogen Idec Inc. and intended to improve walking ability in patients with multiple sclerosis – known in the U.S. as Ampyra – will likely get marketing approval in Europe. The news follows a January report in which the drug got a negative opinion from...

RNA spurs melanoma development

May 10, 2011 9:37 am | by EurekAlert | News | Comments

(Sanford-Burnham Medical Research Institute) Researchers at Sanford-Burnham Medical Research Institute and the University of Queensland show that long, non-coding RNA (lncRNA) levels are altered in human melanoma. Their study, published online May 10 by the journal Cancer Research,...

Advertisement

Who gets treated where for colonoscopy, and how effective is that treatment?

May 10, 2011 7:37 am | by EurekAlert | News | Comments

(Digestive Disease Week) Research being presented at Digestive Disease Week continues to show the effectiveness of colonoscopy for the prevention and detection of colorectal cancer. However, studies show that patients in lower socioeconomic groups are less likely to receive care...

Mayo Clinic researchers find new treatment for constipation

May 10, 2011 6:40 am | by EurekAlert | News | Comments

(Mayo Clinic) Constipation is definitely not a glamorous topic. In reality, it affects nearly 30 million Americans and costs more than $1 billion annually to evaluate and treat. While not often life threatening, the pain, bloating, discomfort, and straining associated with...

NY Presbyterian/Columbia research presented at Digestive Disease Week meeting

May 9, 2011 2:35 pm | by EurekAlert | News | Comments

(New York- Presbyterian Hospital/Columbia University Medical Center) Among those presenting at this year's Digestive Disease Week meeting are physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center. The meeting takes place May 7-10, at McCormick...

Study finds teens often willing to accept free or low-cost rapid HIV testing

May 9, 2011 12:38 pm | by EurekAlert | News | Comments

(Lifespan) New findings from the Bradley Hasbro Children's Research Center suggest widespread, routine HIV testing may be a viable HIV prevention strategy for adolescents.

Yale and Rush University scientists receive Sanberg Awards from ASNTR

May 9, 2011 10:36 am | by EurekAlert | News | Comments

(University of South Florida (USF Health)) At the 18th Annual Conference of the American Society of Neural Therapy and Repair, held in conjunction with the 11th International Conference on Neuronal Transplantation and Repair May 4-8, 2011, in Clearwater Beach, Fla., the ASNTR...

Advertisement

Elsevier acquires Fisterra.com, a reference solution for Spanish primary care professionals

May 9, 2011 9:36 am | by EurekAlert | News | Comments

(Elsevier) Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of Fisterra.com, an award winning, widely used e-clinical reference solution in Spain. Fisterra was launched in 2002 by two...

AGA announces prestigious recognition award recipients

May 9, 2011 8:39 am | by EurekAlert | News | Comments

(American Gastroenterological Association) Each year, the American Gastroenterological Association honors several individuals for their outstanding contributions and achievements in gastroenterology through its prestigious recognition awards.

Advances in HIV/AIDS prevention and treatment

May 9, 2011 6:48 am | by EurekAlert | News | Comments

(New York Academy of Sciences) "Cracking the Safe: Advances in HIV/AIDS Prevention and Treatment" is a one-day symposium at the New York Academy of Sciences examining issues facing researchers working towards the development of an HIV/AIDS vaccine, including updates on current...

Strides in identifying and improving screening practices and treatment for liver diseases

May 8, 2011 10:59 am | by EurekAlert | News | Comments

(Digestive Disease Week) Research being presented at Digestive Disease Week shows that screening individuals for hepatitis C based on age instead of conventional risk factors may help increase detection rates as well as prevent liver disease. Additionally, the rate of vaccination...

Dietary research offers new explanations and treatments approaches for gastrointestinal disorders

May 8, 2011 8:53 am | by EurekAlert | News | Comments

(Digestive Disease Week) Research being presented at Digestive Disease Week (DDW) offers further evidence that diet affects gastrointestinal illnesses, such as gallstones and celiac disease, and that some patients who think their digestive problems are caused by lactose intolerance...

AGA presents cutting-edge research during DDW

May 6, 2011 6:47 am | by EurekAlert | News | Comments

(American Gastroenterological Association) Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week 2011, the largest and most prestigious gastroenterology meeting, from May 7-10, 2011, at McCormick Place, Chicago, Ill. AGA researchers...

BC scientists link to European Consortium studying human genome

May 6, 2011 3:56 am | by EurekAlert | News | Comments

(Genome BC) Vancouver scientists are now part of an International team compiling an enormous bank of resources for research into the functions of all known genes. The development of these biological resources will eventually allow scientists to know how the human genome behaves in...

Surgery reduces risk of mortality due to prostate cancer even for low-risk groups

May 5, 2011 2:37 pm | by EurekAlert | News | Comments

(Uppsala University) A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer...

Elsevier, Redfox Technologies and Microsoft launch innovative e-learning nursing solution

May 5, 2011 2:37 pm | by EurekAlert | News | Comments

(Elsevier) Elsevier, Redfox Technologies and Microsoft today announced the launch of the iCitizen Nursing Skills Netbook, an integrated and affordable e-learning netbook for nurses and nursing students in The Philippines.

Few African-Americans call 911 immediately for stroke symptoms

May 5, 2011 6:45 am | by EurekAlert | News | Comments

(American Heart Association) When given a hypothetical stroke symptoms scenario, 89 percent of African-Americans say they would call 9-1-1. But in a study of black stroke patients, only 12 percent called 9-1-1 immediately. Most African-American stroke patients surveyed called a...

Most blacks report calling a friend, not 911, when facing the symptoms of a stroke

May 5, 2011 6:45 am | by EurekAlert | News | Comments

(Georgetown University Medical Center) Most African-Americans report calling a friend instead of 911 when faced with the symptoms of a stroke, according to a new study that surveyed those hospitalized for a stroke. The findings also indicate that most people, who didn't call for...

Natural protection against radiation

May 4, 2011 12:41 pm | by EurekAlert | News | Comments

(American Chemical Society) In the midst of ongoing concerns about radiation exposure from the Fukushima nuclear power plant in Japan, scientists are reporting that a substance similar to resveratrol -- an antioxidant found in red wine, grapes and nuts -- could protect against...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading